BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24464486)

  • 1. Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.
    Qin L
    Front Med; 2014 Mar; 8(1):24-32. PubMed ID: 24464486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
    Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
    Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
    Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
    Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
    Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma.
    Dong QZ; Zhang XF; Zhao Y; Jia HL; Zhou HJ; Dai C; Sun HJ; Qin Y; Zhang WD; Ren N; Ye QH; Qin LX
    Hepatology; 2013 Mar; 57(3):1024-34. PubMed ID: 23079960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
    Zhou C; Zhou HJ; Zhang XF; Lou LL; Ye QH; Zheng Y; Wang J; Zhu HT; Dong QZ; Jia HL; Zhu WW; Guo L; Zhao Y; Gao DM; Qin LX
    Ann Surg Oncol; 2013 Mar; 20(3):929-37. PubMed ID: 23203407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
    Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
    Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.
    Xue YH; Zhang XF; Dong QZ; Sun J; Dai C; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX
    Hepatology; 2010 Dec; 52(6):2012-22. PubMed ID: 20890897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation and prognostic value of osteopontin and Bcl-2 in hepatocellular carcinoma patients after curative resection.
    Deng B; Zhang XF; Zhu XC; Huang H; Jia HL; Ye QH; Dong QZ; Qin LX
    Oncol Rep; 2013 Dec; 30(6):2795-803. PubMed ID: 24065086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
    Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
    Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up.
    Cabiati M; Gaggini M; Cesare MM; Caselli C; De Simone P; Filipponi F; Basta G; Gastaldelli A; Del Ry S
    Cytokine; 2017 Nov; 99():59-65. PubMed ID: 28711012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
    Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
    Zhang H; Ye QH; Ren N; Zhao L; Wang YF; Wu X; Sun HC; Wang L; Zhang BH; Liu YK; Tang ZY; Qin LX
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):709-17. PubMed ID: 16786357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma].
    Zhang H; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):985-8. PubMed ID: 16194354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of osteopontin as a novel marker for early hepatocellular carcinoma.
    Shang S; Plymoth A; Ge S; Feng Z; Rosen HR; Sangrajrang S; Hainaut P; Marrero JA; Beretta L
    Hepatology; 2012 Feb; 55(2):483-90. PubMed ID: 21953299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.
    Sun J; Xu HM; Zhou HJ; Dong QZ; Zhao Y; Fu LY; Hei ZY; Ye QH; Ren N; Jia HL; Qin LX
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):1-7. PubMed ID: 19593583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
    Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
    J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.